Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals is a transdermal synthetic cannabinoid treatments founded in 2014.

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Cannabis industry

Biomedical engineering

Synthetic cannabinoids

Location

Devon, Pennsylvania

B2X

0

CEO

Pitchbook URL

pitchbook.com/profiles.../98203-69

Number of Employees (Ranges)

11 – 50

Phone Number

+14845817505

Full Address

80 W. Lancaster Avenue, Suite 300 Devon, PA 19333

CIK Number

Place of Incorporation

0

IRS Number

260,389,4330

Founded Date

2014

0

Competitors

Ovid Therapeutics

Stock Symbol

ZYNE

Exchange

Board of Directors

Kenneth I. Moch

0

Warren D. Cooper

0

0

0

William J. Federici

0

0

CFO

Jim Fickenscher

0

NAICS Code

325,4120

CAGE Code

396G00

Patents Assigned (Count)

9

Country

Other attributes

Contact Page URL

zynerba.com/about-us/...ontact-us/

SIC Code

2,8340

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Zynerba Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool